Stay updated on Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial

Sign up to get notified when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical trial record for the GHB16L2 influenza vaccine is displayed, including its study details, participant criteria, interventions, and outcome measures. The record indicates that the study is completed and is no longer recruiting participants.
    Difference
    40%
    Check dated 2026-11-13T05:13:53.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-30T06:24:41.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A notice announces NIH’s terminology transition, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-23T03:58:27.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label updates from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-16T08:41:13.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the study record page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-09T07:43:18.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    A 403 Forbidden message appears in the study record area, with a Home link, instead of the expected study content.
    Difference
    0.5%
    Check dated 2026-10-02T06:56:28.000Z thumbnail image

Stay in the know with updates to Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.